Individual Patient Expanded Access for Human Acellular Vessel (HAV)

Status Available

Clinical Trial Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options and are not eligible for an HAV clinical study

Clinical Trial Description

Procedure for Requesting Expanded Access: The treating physician requesting expanded access must contact Humacyte directly with the basis for the request. Please include your contact information so that Humacyte may follow up with you directly. General Criteria: We will evaluate and respond to each expanded-access request that we receive on a case-by-case basis. Humacyte will consider the nature of the request, the patient's health, the available medical and scientific information about the investigational product, the balance of risk and potential benefit to the patient, the availability of investigational product, and the potential regulatory impact. Anticipated Timing: If you contact Humacyte as described above, Humacyte anticipates that we will acknowledge receipt within ten (10) business days or less. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03631056
Study type	Expanded Access
Source	Humacyte, Inc.
Contact	Mauricio Berdugo, MD, MPH
Phone	919-313-9633
Email	mberdugo@humacyte.com
Status	Available
Phase

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05971407` - The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults	N/A
Enrolling by invitation	`NCT03683186` - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension	Phase 3
Recruiting	`NCT04584632` - The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery	N/A
Recruiting	`NCT04390672` - Multivessel TALENT	N/A
Completed	`NCT01915368` - Determining Optimal Post-Stroke Exercise (DOSE)	N/A
Completed	`NCT01684826` - X-ray Dose Reduction Study for Cardiac Angiography and Intervention	N/A
Completed	`NCT01417910` - Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients	N/A
Terminated	`NCT00935766` - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries	Phase 3
Unknown status	`NCT01748383` - The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)	Phase 2
Recruiting	`NCT05907564` - Aventus Thrombectomy System Pulmonary Embolism Clinical Study	N/A
Recruiting	`NCT03732612` - Inflammation in Vascular Disease
Completed	`NCT00000614` - Prevention of Recurrent Venous Thromboembolism (PREVENT)	Phase 3
Completed	`NCT00000530` - Raynaud's Treatment Study (RTS)	Phase 3
Completed	`NCT00000539` - Arterial Disease Multifactorial Intervention Trial (ADMIT)	Phase 3
Completed	`NCT00000479` - Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer	Phase 3
Completed	`NCT00000474` - Prevention and Treatment of Hypertension Study (PATHS)	Phase 3
Completed	`NCT00000528` - Trials of Hypertension Prevention (TOHP)	Phase 3
Completed	`NCT00000509` - Potassium and Sodium to Control Blood Pressure in Hypertensives	Phase 3
Completed	`NCT00000501` - Hypertension Prevention Trial (HPT) Feasibility Study	Phase 2
Completed	`NCT00000499` - Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)	Phase 2